{"id":"https://openalex.org/W4296205052","doi":"https://doi.org/10.1016/j.toxlet.2022.07.311","title":"P05-02 Use of a dynamic skin and liver co-culture model to investigate the effect of application route on the metabolism of the hair dye, 4-amino-2-hydroxytoluene","display_name":"P05-02 Use of a dynamic skin and liver co-culture model to investigate the effect of application route on the metabolism of the hair dye, 4-amino-2-hydroxytoluene","publication_year":2022,"publication_date":"2022-09-01","ids":{"openalex":"https://openalex.org/W4296205052","doi":"https://doi.org/10.1016/j.toxlet.2022.07.311"},"language":"en","primary_location":{"id":"doi:10.1016/j.toxlet.2022.07.311","doi":"https://doi.org/10.1016/j.toxlet.2022.07.311","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.toxlet.2022.07.311","pdf_url":null,"source":{"id":"https://openalex.org/S205878144","display_name":"Toxicology Letters","issn_l":"0378-4274","issn":["0378-4274","1879-3169"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicology Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011859618","display_name":"Ilka Maschmeyer","orcid":"https://orcid.org/0000-0001-5356-4799","observed_orcids":["https://orcid.org/0000-0001-5356-4799"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I. Maschmeyer","raw_affiliation_strings":["Tissuse GmbH, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tissuse GmbH, Berlin, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015475696","display_name":"T.P. Tao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T.P. Tao","raw_affiliation_strings":["Tissuse GmbH, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tissuse GmbH, Berlin, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067443701","display_name":"Jochen K\u00fchnl","orcid":"https://orcid.org/0000-0001-8421-9381","observed_orcids":["https://orcid.org/0000-0001-8421-9381"]},"institutions":[{"id":"https://openalex.org/I106618798","display_name":"Beiersdorf (Germany)","ror":"https://ror.org/04aqg9s78","country_code":"DE","type":"company","lineage":["https://openalex.org/I106618798"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"J. K\u00fchnl","raw_affiliation_strings":["Beiersdorf AG, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beiersdorf AG, Hamburg, Germany","institution_ids":["https://openalex.org/I106618798"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075739155","display_name":"Katrin Brandmair","orcid":"https://orcid.org/0000-0001-5528-3130","observed_orcids":["https://orcid.org/0000-0001-5528-3130"]},"institutions":[{"id":"https://openalex.org/I106618798","display_name":"Beiersdorf (Germany)","ror":"https://ror.org/04aqg9s78","country_code":"DE","type":"company","lineage":["https://openalex.org/I106618798"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"K. Brandmair","raw_affiliation_strings":["Beiersdorf AG, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beiersdorf AG, Hamburg, Germany","institution_ids":["https://openalex.org/I106618798"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085994300","display_name":"Julia Przibilla","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Przibilla","raw_affiliation_strings":["Pharmacelsus GmbH, Saarbr\u00fccken, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacelsus GmbH, Saarbr\u00fccken, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049971921","display_name":"Andreas G. Schepky","orcid":"https://orcid.org/0000-0001-5258-3605","observed_orcids":["https://orcid.org/0000-0001-5258-3605"]},"institutions":[{"id":"https://openalex.org/I106618798","display_name":"Beiersdorf (Germany)","ror":"https://ror.org/04aqg9s78","country_code":"DE","type":"company","lineage":["https://openalex.org/I106618798"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"A. Schepky","raw_affiliation_strings":["Beiersdorf AG, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beiersdorf AG, Hamburg, Germany","institution_ids":["https://openalex.org/I106618798"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064780645","display_name":"Carine Jacques","orcid":"https://orcid.org/0000-0001-6839-6417","observed_orcids":["https://orcid.org/0000-0001-6839-6417"]},"institutions":[{"id":"https://openalex.org/I4210143394","display_name":"Pierre Fabre (France)","ror":"https://ror.org/04hdhz511","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143394"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C. Jacques-Jamin","raw_affiliation_strings":["Pierre Fabre Dermo-Cosm\u00e9tique, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pierre Fabre Dermo-Cosm\u00e9tique, Toulouse, France","institution_ids":["https://openalex.org/I4210143394"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004745328","display_name":"Camille G\u00e9ni\u00e8s","orcid":"https://orcid.org/0000-0003-3535-4530","observed_orcids":["https://orcid.org/0000-0003-3535-4530"]},"institutions":[{"id":"https://openalex.org/I4210143394","display_name":"Pierre Fabre (France)","ror":"https://ror.org/04hdhz511","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143394"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C. Genies","raw_affiliation_strings":["Pierre Fabre Dermo-Cosm\u00e9tique, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pierre Fabre Dermo-Cosm\u00e9tique, Toulouse, France","institution_ids":["https://openalex.org/I4210143394"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086315111","display_name":"Nicky J. Hewitt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117215","display_name":"Cosmetics Europe","ror":"https://ror.org/02errzw26","country_code":"BE","type":"other","lineage":["https://openalex.org/I4210117215"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"N. Hewitt","raw_affiliation_strings":["Cosmetics Europe, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cosmetics Europe, Brussels, Belgium","institution_ids":["https://openalex.org/I4210117215"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3520,"currency":"USD","value_usd":3520},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.09703324,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"368","issue":null,"first_page":"S109","last_page":"S109"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.6919000148773193,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.6919000148773193,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13325","display_name":"Dye analysis and toxicity","score":0.066600002348423,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11033","display_name":"Contact Dermatitis and Allergies","score":0.03370000049471855,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9229999780654907},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.8330000042915344},{"id":"https://openalex.org/keywords/rhesus-macaques","display_name":"rhesus monkeys","score":0.9169999957084656},{"id":"https://openalex.org/keywords/salicylic-acid","display_name":"salicylic acid","score":0.8799999952316284},{"id":"https://openalex.org/keywords/dose-proportionality","display_name":"dose proportionality","score":0.7620000243186951},{"id":"https://openalex.org/keywords/traditional-chinese-medicine","display_name":"traditional Chinese medicine","score":0.75},{"id":"https://openalex.org/keywords/hplc-analysis","display_name":"HPLC assay","score":0.5659999847412109}],"concepts":[{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.8636029958724976},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.8051164150238037},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7600284814834595},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6098625063896179},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.5914462804794312},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5167586207389832},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.47921305894851685},{"id":"https://openalex.org/C2778221352","wikidata":"https://www.wikidata.org/wiki/Q193572","display_name":"Salicylic acid","level":2,"score":0.4461369812488556},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3479788303375244},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.15788045525550842},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12315249443054199},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0593910813331604}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.toxlet.2022.07.311","doi":"https://doi.org/10.1016/j.toxlet.2022.07.311","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.toxlet.2022.07.311","pdf_url":null,"source":{"id":"https://openalex.org/S205878144","display_name":"Toxicology Letters","issn_l":"0378-4274","issn":["0378-4274","1879-3169"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Toxicology Letters","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4295280132","https://openalex.org/W2075455354","https://openalex.org/W1748045456","https://openalex.org/W2016487147","https://openalex.org/W2942049316","https://openalex.org/W2148124507","https://openalex.org/W2464453938","https://openalex.org/W2041361854","https://openalex.org/W2367413023","https://openalex.org/W2806028774"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2022-09-18T00:00:00"}